Acne varioliformis

L12_ACNE_VARIOLIFORMIS

acne: An inflammatory process of the sebaceous glands which is characterized by comedones, nodules, papules and/or pustules on the skin.

Suggest a new description

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 L70.2
  • Hospital discharge: ICD-9 7060A
  • Hospital discharge: ICD-8 70601
  • Cause of death: ICD-10 L70.2
  • Cause of death: ICD-9 7060A
  • Cause of death: ICD-8 70601

2 out of 7 registries used, show all original rules.

89

4. Check minimum number of events

None

89

5. Include endpoints

None

89

6. Filter based on genotype QC (FinnGen only)

89

Control definitions (FinnGen only)

Control exclude
L12_DISORDSKINAPPENDIX

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
L70
Name in latin
Acne varioliformis

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 575 296 276
Only index persons 520 275 245
Unadjusted period prevalence (%)
Whole population 0.01 0.01 0.01
Only index persons 0.01 0.01 0.01
Median age at first event (years)
Whole population 54.38 52.45 56.29
Only index persons 51.46 50.11 52.97

-FinnGen-

Key figures

All Female Male
Number of individuals 89 50 39
Unadjusted period prevalence (%) 0.02 0.02 0.02
Median age at first event (years) 50.91 47.48 55.29

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
85
Matched controls
849
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
L70.2
ICD-10 Finland
Acne varioliformis
7607.2
108.5
81
*
L73.2
ICD-10 Finland
Hidradenitis suppurativa
+∞
10.6
10
*
A10AE04
ATC
insulin glargine; parenteral
7.1
8.2
20
35
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
12.6
8.1
14
13
177
Kela drug reimbursment
Insulin glargine 300 U / ml
49.7
7.9
9
*
N05BA04
ATC
oxazepam; oral
4.0
7.5
35
126
ZXE00
NOMESCO Finland
One hour or less
3.6
7.5
46
208
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
13.7
7.3
12
10
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
8.9
7.3
15
20
TPH07
NOMESCO Finland
Cathetrisation of artery
7.3
7.2
17
28
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
6.3
7.2
19
37
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
5.1
6.9
22
54
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
11.4
6.8
12
12
Z2221
NOMESCO Finland
Medical doctor
3.7
6.6
34
130
S97
ICPC
Chronic ulcer skin
8.1
6.5
14
20
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
75.3
6.5
7
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
4.9
6.4
21
53
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
+∞
6.3
6
*
PE1AT
NOMESCO Finland
Femoral artery PTA
+∞
6.3
6
*
SPAT1148
SPAT
Treatment of chronic ulcer or burn
4.8
6.3
21
54
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
13.9
6.3
10
8
N06AX16
ATC
venlafaxine; oral
4.6
6.1
21
56

Mortality – FinRegistry

Association

Association between endpoint L12_ACNE_VARIOLIFORMIS and mortality.

Females

Parameter HR [95% CI] p-value
L12_ACNE_VARIOLIFORMIS 3.159 [1.69, 5.9] < 0.001
Birth year 0.994 [0.99, 1.0] 0.158

During the follow-up period (1.1.1998 — 31.12.2019), 69 out of 248 females with L12_ACNE_VARIOLIFORMIS died.

Males

Parameter HR [95% CI] p-value
L12_ACNE_VARIOLIFORMIS 2.79 [1.74, 4.47] < 0.001
Birth year 0.985 [0.97, 0.99] 0.002

During the follow-up period (1.1.1998 — 31.12.2019), 74 out of 222 males with L12_ACNE_VARIOLIFORMIS died.

Mortality risk

Mortality risk for people of age

years, who have L12_ACNE_VARIOLIFORMIS.

N-year risk Females Males
1 0.295% 0.545%
5 1.815% 3.121%
10 4.642% 7.312%
15 8.799% 13.825%
20 14.855% 22.752%

Relationships between endpoints

Index endpoint: L12_ACNE_VARIOLIFORMIS – Acne varioliformis

GWS hits: -

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data